FMT+SOX+Sintilimab As First-line Treatment for Advanced Gastric Cancer
Clinical trial NCT06405113 · RECRUITING
Trial details
- NCT number
- NCT06405113
- Sponsor
- Changzhou No.2 People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2027-06-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.